相关实验视频
Updated: Jun 13, 2025

04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
328
减肥药疗:当前和未来的治疗方法
Gabriela Jordan1, Sigrid Young1, José O Alemán2
1Department of Medicine, Margaret Corbin Campus of the VA New York Harbor Health Care System, New York, NY, USA; Laboratory of Translational Obesity Research, NYU Langone Health, New York, NY, USA.
Gastrointestinal endoscopy clinics of North America
|September 14, 2024
概括
肥胖药物治疗和手术提供减肥,但体重可以恢复. 结合治疗可能会改善长期的结果,但最佳时机需要更多的研究.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
- 手术创新 在外科创新.
背景情况:
- 全球肥胖率的上升是一个重大的公共卫生挑战.
- 目前的肥胖治疗包括改变生活方式,药物治疗和手术干预.
- 现有的药物疗法具有不同的疗效和患者坚持挑战.
研究的目的:
- 审查当前的肥胖治疗方法,包括药物治疗和手术选择.
- 探索将药物治疗与手术干预相结合以提高体重管理的潜力.
- 确定关于这些治疗策略的最佳整合的知识差距.
主要方法:
- 食品和药物管理局批准的肥胖药物的文献综述.
- 对减肥手术和内镜手术的分析.
- 综合结合疗法和干预后体重恢复的证据.
主要成果:
- 有五种FDA批准的肥胖药物可供使用:奥利斯塔特,芬特明/托皮拉玛,纳尔特雷/布普罗,利拉格卢提德3.0毫克和塞马格卢提德2.4毫克.
- 腹部和内镜手术提供持久的减肥,但可以随之而后的体重恢复或平原.
- 多模式或多激素药物疗法在解决手术后的体重管理挑战方面表现有前途.
结论:
- 药物治疗和手术是治疗肥胖的主要工具.
- 组合疗法是一个有希望的策略,可以克服个体治疗的局限性.
- 进一步的研究对于确定药物治疗与手术和内镜干预相结合的最佳时机至关重要.
相关概念视频
Diabetes: Management and Pharmacotherapy
245
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
245
Drug Therapy
40
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
40
Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118
Antidepressant Drugs: MAOIs and Other Agents
204
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
204
Glucagon-like Receptor Agonists
306
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
306
Psychosis: Goals of Pharmacotherapy
110
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
110

